Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00164424Phase 3Completed
A Phase 3 trial of aciclovir in genital ulcer disease (GUD), herpes simplex virus type 2 infection, sponsored by Centers for Disease Control and Prevention. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00164424.